SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: joemjo who wrote (609)12/4/1997 1:28:00 PM
From: joemjo  Respond to of 1894
 
Is this the important section? Somebody seems to have changed their mind or new interest has been created.

<The Company has recently seen an increase in interest in its AcCell(TM)
Cytopathology System following the recent report of significant productivity
gains in Pap screening after the system was installed at Detroit Medical
Center's DMC University Laboratories. Gombrich commented, "These results have
created a tremendous awareness of the AcCell System in the marketplace, and
AccuMed has proven that its products can give a laboratory the edge it needs
to thrive in the cost-competitive Pap test screening business."
The Company has also seen increased interest in its Sensititre(TM)
microbiology product lines and has recently received several sizable orders.>



To: joemjo who wrote (609)12/4/1997 1:31:00 PM
From: Frank Buck  Read Replies (1) | Respond to of 1894
 
Todd,

Thanks for posting that. I missed out at buying more shares at $1.5.
Wouldn't you know. That's OK. I am glad we are staring to see some upside movement here even if I didn't add at these low levels.

Hopefully within a few weeks we will all be questioning why we didn't add heavily to our current positions while the stock was setting new lows.

Look for more releases to follow.

Frank


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News